Yali Zhu

Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects

James E. Patrick, Teddy Kosoglou, Kathe Stauber et al. · Drug Metabolism and Disposition · 2002 · 165 citations

Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer

Monica Mita, Anil A. Joy, Alain C. Mita et al. · Clinical Breast Cancer · 2013 · 151 citations

Advanced Breast Cancer, Breast Oncology, Oncology +8

A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies

John Nemunaitis, Karen Small, Paul T. Kirschmeier et al. · Journal of Translational Medicine · 2013 · 127 citations · Full text

Movement of Potato Spindle Tuber Viroid Reveals Regulatory Points of Phloem-Mediated RNA Traffic

Yali Zhu, Yijun Qi, Yan Xun et al. · PLANT PHYSIOLOGY · 2002 · 105 citations · Full text

A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan

Sunil Sharma, Nancy E. Kemeny, David P. Kelsen et al. · Annals of Oncology · 2002 · 104 citations

Oncology, Phase Ii Trial, Medicine +6